Skip to Content

PharmaCielo Ltd Ordinary Shares PCLO

Morningstar Rating
CAD 0.15 0.01 (3.23%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PCLO is trading at a 49% discount.
Price
CAD 0.17
Fair Value
CAD 1.34
Uncertainty
Extreme
1-Star Price
CAD 3.67
5-Star Price
CAD 4.28
Economic Moat
Vchdn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PCLO is a good fit for your portfolio.

Trading Information

Previous Close Price
CAD 0.16
Day Range
CAD 0.150.17
52-Week Range
CAD 0.110.29
Bid/Ask
CAD 0.15 / CAD 0.16
Market Cap
CAD 25.56 Mil
Volume/Avg
179,700 / 176,932

Key Statistics

Price/Earnings (Normalized)
Price/Sales
8.36
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
268

Valuation

Metric
PCLO
Price/Earnings (Normalized)
Price/Book Value
8.75
Price/Sales
8.36
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PCLO
Quick Ratio
0.16
Current Ratio
0.45
Interest Coverage
−4.23
Quick Ratio
PCLO

Profitability

Metric
PCLO
Return on Assets (Normalized)
−36.24%
Return on Equity (Normalized)
−179.21%
Return on Invested Capital (Normalized)
−35.96%
Return on Assets
PCLO
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ALjkzyqlrybXzlt$72.4 Bil
MKKGY
Merck KGaA ADRMggphdsmcNhkdt$70.8 Bil
HLN
Haleon PLC ADRVqxrjpbxmWcz$38.2 Bil
VTRS
Viatris IncYvyvvdtnRnv$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRLjcxznnrDynj$12.5 Bil
CTLT
Catalent IncBljyrffVvrnzj$10.1 Bil
PRGO
Perrigo Co PLCXvwjhcjjZwdd$4.3 Bil
CURLF
Curaleaf Holdings IncGshgsftdxFxhvj$3.7 Bil
PBH
Prestige Consumer Healthcare IncDkxssbgfxVgmnqk$3.5 Bil
GTBIF
Green Thumb Industries IncWtlcqpqhdRnm$2.9 Bil

Sponsor Center